Donenberg Phillip B.

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$157,333.70
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Donenberg Phillip B.

The largest purchase of all time was on 2023-08-16 and amounted to 111111 share of Taysha Gene Therapies, Inc. for $100,000.

Biography of Donenberg Phillip B.

No biography is available at this moment.

2023-08-16PurchaseTaysha Gene Therapies, Inc.
TSHA
director
111,111
0.0807%
$0.90$100,000+21.5%
2022-02-02PurchaseTaysha Gene Therapies, Inc.
TSHA
director
3,000
0.008%
$7.78$23,340-57.83%
2011-08-08PurchaseANI Pharmaceuticals, Inc.
ANIP
Sr. VP of Finance, CFO & Secy
2,000
0.0021%
$2.23$4,460-65.53%
2011-08-05PurchaseANI Pharmaceuticals, Inc.
ANIP
Sr. VP of Finance, CFO & Secy
2,000
0.0018%
$2.19$4,380-70.04%
2011-01-21PurchaseANI Pharmaceuticals, Inc.
ANIP
Sr. VP of Finance, CFO & Sec'y
2,000
0.0024%
$1.88$3,760+27.03%
2011-01-19PurchaseANI Pharmaceuticals, Inc.
ANIP
Sr. VP of Finance, CFO & Sec'y
2,000
0.0023%
$1.88$3,760+23.04%
2008-12-31PurchaseANI Pharmaceuticals, Inc.
ANIP
CFO, Treasurer and Secretary
6,000
0.0219%
$1.00$6,000+79%
2007-12-14PurchaseANI Pharmaceuticals, Inc.
ANIP
CFO, Treasurer and Secretary
2,000
0.008%
$3.77$7,535+6.23%
2006-07-20PurchaseANI Pharmaceuticals, Inc.
ANIP
Sr VP of Finance, CFO, Secy
1,000
0.0046%
$1.95$1,949+58.42%
2003-08-04PurchaseANI Pharmaceuticals, Inc.
ANIP
Sr VP of Finance, CFO, Secy
1,000
0.0069%
$2.15$2,150+82.69%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.